(3R,4S)-rel-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate

Catalog No. :
ACZCYV210
CAS No. :
1273565-65-3
Molecular Formula :
C10H19FN2O2
Molecular Weight :
218.27

IUPAC Name:tert-butyl (3R,4S)-3-amino-4-fluoropiperidine-1-carboxylate

(3R,4S)-rel-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$83.00Login to see priceIn stockInquiry
1g95%$245.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4S)-rel-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate
IUPAC Nametert-butyl (3R,4S)-3-amino-4-fluoropiperidine-1-carboxylate
MDL No.MFCD18791212
Molecular FormulaC10H19FN2O2
Molecular Weight218.27
SMILESO=C(OC(C)(C)C)N1CC[C@H](F)[C@H](N)C1
InChI KeyCVHJEFDRBTZVEL-JGVFFNPUSA-N
Synonym1290191-73-9 | (3S,4R)-tert-butyl 3-amino-4-fluoropiperidine-1-carboxylate | 1273565-65-3 | tert-butyl (3S,4R)-3-amino-4-fluoropiperidine-1-carboxylate | (3s,4r)-rel-3-amino-1-boc-4-fluoropiperidine | (3S,4R)-1-Boc-4-fluoro-3-piperidinamine | tert-butyl cis-3-amino-4
CAS No.1273565-65-3
PubChem CID72207953

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZCYV210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZCYV210 route product structure diagram
    ACZCYV2101273565-65-3 In Stock
Inquiry

2. ACZCYV210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZCYV210 route product structure diagram
    ACZCYV2101273565-65-3 In Stock
Inquiry

Comments (0)